Ergoteles’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-35,309
| Closed | -$1.66M | – | 686 |
|
|
2023
Q2 | $1.66M | Buy |
35,309
+8,440
| +31% | +$397K | 0.08% | 321 |
|
|
2023
Q1 | $1.13M | Sell |
26,869
-23,198
| -46% | -$973K | 0.04% | 448 |
|
|
2022
Q4 | $1.91M | Buy |
+50,067
| New | +$1.91M | 0.07% | 293 |
|
|
2022
Q1 | – | Sell |
-19,195
| Closed | -$817K | – | 1587 |
|
|
2021
Q4 | $817K | Buy |
19,195
+6,634
| +53% | +$282K | 0.03% | 482 |
|
|
2021
Q3 | $557K | Sell |
12,561
-70,372
| -85% | -$3.12M | 0.02% | 540 |
|
|
2021
Q2 | $4.71M | Buy |
82,933
+63,330
| +323% | +$3.6M | 0.11% | 232 |
|
|
2021
Q1 | $1.47M | Buy |
19,603
+12,793
| +188% | +$957K | 0.05% | 322 |
|
|
2020
Q4 | $589K | Sell |
6,810
-62,974
| -90% | -$5.45M | 0.02% | 428 |
|
|
2020
Q3 | $4.27M | Buy |
+69,784
| New | +$4.27M | 0.56% | 31 |
|